top of page

Chapter 8-- HOW DOES IT HAPPEN THAT THE GOOD EFFECTS OF HOCL PERSIST? -- Pioneer of HOCL Science with Jeffrey F. Williams

Nature does this by surrounding the HOCl with taurine. And our bodies are full of taurine. It's the most abundant amino acid in our bodies. Our neutrophils, our white blood cells in particular, have a lot of it in them. And what it does is it serves as a sponge. So all that HOCl that didn't get used up killing a staphylococcus, now gets sponged up by taurine. 

 

The HOCl reacts with it, changes it, converts it into a compound that we call NCT. And that NCT continues the good work. 

 

It's very strongly, powerfully anti-microbial. Doesn't act lightning fast, but it acts with a lot of power. And then it stimulates all the good things that we associate with HOCl. Stimulates healing by making little blood vessels form that bring new blood to a wound or a lesion. 

 

Shoots down the bad things that happen in inflammation where there's an excess of some proteins sometimes, some harmful enzymes, it shuts those down. 

 

So NCT is the continuing goodness that we get from HOCl that happens in our bodies with natural HOCl that we make ourselves. But it also happens when we flood a wound or we rinse our gums with HOCl. 

 

Wherever there's a bleeding point, we're making NCT and that carries on the good work and especially the healing.


 

-- Jeffrey F. Williams, PhD, BVSc, MRCVS, microbiologist and infectious disease expert, has devoted his career to researching, inventing and bringing to market solutions that have improved the lives and health of people all over the world. 

 

-- Professor of Microbiology and Molecular Genetics, Michigan State University (Emeritus)

 

-- Elected Fellow of the American Association for the Advancement of Science (AAAS)

 

-- Holder of 30+ patents covering water treatment, disease control, odor control

 

-- Author of 200+ scientific papers and textbook chapters

 

-- Member of the Board of Counselors, National Institute of Allergy and Infectious Diseases, National Institute of Health (1984-88)

 

-- ​Chairman of a World Health Organization research committee on tropical diseases (based in Geneva) (1985-1989)

 

-- Chief Science Officer, HOCL producer that is world leader in hypochlorous acid technology and manufacturing (2014-2024)

bottom of page